nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—ABCG2—hematologic cancer	0.3	1	CbGaD
Nitrofurantoin—POR—Daunorubicin—hematologic cancer	0.173	0.333	CbGbCtD
Nitrofurantoin—ABCG2—Clofarabine—hematologic cancer	0.0535	0.103	CbGbCtD
Nitrofurantoin—POR—Doxorubicin—hematologic cancer	0.0452	0.0871	CbGbCtD
Nitrofurantoin—ABCG2—Daunorubicin—hematologic cancer	0.0314	0.0605	CbGbCtD
Nitrofurantoin—ABCG2—Teniposide—hematologic cancer	0.0273	0.0525	CbGbCtD
Nitrofurantoin—ABCG2—Cladribine—hematologic cancer	0.0262	0.0504	CbGbCtD
Nitrofurantoin—ABCG2—Imatinib—hematologic cancer	0.024	0.0463	CbGbCtD
Nitrofurantoin—ABCG2—Nilotinib—hematologic cancer	0.0219	0.0421	CbGbCtD
Nitrofurantoin—ABCG2—Dasatinib—hematologic cancer	0.0193	0.0372	CbGbCtD
Nitrofurantoin—ABCG2—Mitoxantrone—hematologic cancer	0.0191	0.0367	CbGbCtD
Nitrofurantoin—ABCG2—Irinotecan—hematologic cancer	0.015	0.0289	CbGbCtD
Nitrofurantoin—ABCG2—Vincristine—hematologic cancer	0.0131	0.0253	CbGbCtD
Nitrofurantoin—ABCG2—Cisplatin—hematologic cancer	0.0122	0.0236	CbGbCtD
Nitrofurantoin—ABCG2—Etoposide—hematologic cancer	0.012	0.0232	CbGbCtD
Nitrofurantoin—ABCG2—Dexamethasone—hematologic cancer	0.00989	0.019	CbGbCtD
Nitrofurantoin—ABCG2—Doxorubicin—hematologic cancer	0.00821	0.0158	CbGbCtD
Nitrofurantoin—ABCG2—Methotrexate—hematologic cancer	0.00795	0.0153	CbGbCtD
Nitrofurantoin—ABCG2—Abacavir transmembrane transport—SLC22A1—hematologic cancer	0.00047	0.0969	CbGpPWpGaD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PIM2—hematologic cancer	0.000347	0.0715	CbGpPWpGaD
Nitrofurantoin—ABCG2—Abacavir transport and metabolism—SLC22A1—hematologic cancer	0.00027	0.0556	CbGpPWpGaD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—LYL1—hematologic cancer	0.000263	0.0542	CbGpPWpGaD
Nitrofurantoin—ABCG2—Abacavir transmembrane transport—ABCB1—hematologic cancer	0.000262	0.0539	CbGpPWpGaD
Nitrofurantoin—ABCG2—Irinotecan Pathway—UGT1A1—hematologic cancer	0.000212	0.0437	CbGpPWpGaD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—CDA—hematologic cancer	0.00019	0.0391	CbGpPWpGaD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—NSD1—hematologic cancer	0.00017	0.0349	CbGpPWpGaD
Nitrofurantoin—ABCG2—Abacavir transport and metabolism—ABCB1—hematologic cancer	0.00015	0.031	CbGpPWpGaD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—BCR—hematologic cancer	0.000138	0.0285	CbGpPWpGaD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—ABCC3—hematologic cancer	0.000114	0.0234	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—BNIP3—hematologic cancer	0.000114	0.0234	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—GATA2—hematologic cancer	0.000105	0.0216	CbGpPWpGaD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CSF1R—hematologic cancer	9.74e-05	0.0201	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—ID2—hematologic cancer	9.03e-05	0.0186	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—EPO—hematologic cancer	7.76e-05	0.016	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—MCL1—hematologic cancer	7.68e-05	0.0158	CbGpPWpGaD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—hematologic cancer	7.51e-05	0.0155	CbGpPWpGaD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—SMUG1—hematologic cancer	7.09e-05	0.0146	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—CA9—hematologic cancer	7.02e-05	0.0145	CbGpPWpGaD
Nitrofurantoin—ABCG2—Iron uptake and transport—TFRC—hematologic cancer	6.68e-05	0.0138	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—NPM1—hematologic cancer	6.02e-05	0.0124	CbGpPWpGaD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—hematologic cancer	5.79e-05	0.0119	CbGpPWpGaD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—hematologic cancer	5.6e-05	0.0115	CbGpPWpGaD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—MTHFR—hematologic cancer	4.96e-05	0.0102	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—TFRC—hematologic cancer	4.74e-05	0.00977	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—EPO—hematologic cancer	4.57e-05	0.0094	CbGpPWpGaD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—hematologic cancer	4.35e-05	0.00896	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—CXCR4—hematologic cancer	4.25e-05	0.00876	CbGpPWpGaD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—hematologic cancer	4.21e-05	0.00868	CbGpPWpGaD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—hematologic cancer	3.98e-05	0.0082	CbGpPWpGaD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—hematologic cancer	3.92e-05	0.00807	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—CREBBP—hematologic cancer	3.77e-05	0.00777	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—ABCB1—hematologic cancer	3.32e-05	0.00684	CbGpPWpGaD
Nitrofurantoin—Anaphylactic shock—Betamethasone—hematologic cancer	3.27e-05	0.000186	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Dexamethasone—hematologic cancer	3.27e-05	0.000186	CcSEcCtD
Nitrofurantoin—Diarrhoea—Mitoxantrone—hematologic cancer	3.27e-05	0.000186	CcSEcCtD
Nitrofurantoin—Diarrhoea—Irinotecan—hematologic cancer	3.27e-05	0.000186	CcSEcCtD
Nitrofurantoin—Vomiting—Carmustine—hematologic cancer	3.27e-05	0.000186	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Epirubicin—hematologic cancer	3.26e-05	0.000185	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Etoposide—hematologic cancer	3.25e-05	0.000185	CcSEcCtD
Nitrofurantoin—Dizziness—Vincristine—hematologic cancer	3.24e-05	0.000185	CcSEcCtD
Nitrofurantoin—Rash—Carmustine—hematologic cancer	3.24e-05	0.000184	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Prednisone—hematologic cancer	3.24e-05	0.000184	CcSEcCtD
Nitrofurantoin—Vomiting—Alitretinoin—hematologic cancer	3.24e-05	0.000184	CcSEcCtD
Nitrofurantoin—Paraesthesia—Triamcinolone—hematologic cancer	3.24e-05	0.000184	CcSEcCtD
Nitrofurantoin—Drowsiness—Doxorubicin—hematologic cancer	3.23e-05	0.000184	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Prednisolone—hematologic cancer	3.23e-05	0.000184	CcSEcCtD
Nitrofurantoin—Anaemia—Prednisone—hematologic cancer	3.22e-05	0.000184	CcSEcCtD
Nitrofurantoin—Headache—Carmustine—hematologic cancer	3.22e-05	0.000183	CcSEcCtD
Nitrofurantoin—Dyspnoea—Triamcinolone—hematologic cancer	3.21e-05	0.000183	CcSEcCtD
Nitrofurantoin—Rash—Alitretinoin—hematologic cancer	3.21e-05	0.000183	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	3.2e-05	0.000182	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Dexamethasone—hematologic cancer	3.2e-05	0.000182	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Betamethasone—hematologic cancer	3.2e-05	0.000182	CcSEcCtD
Nitrofurantoin—Vomiting—Ifosfamide—hematologic cancer	3.2e-05	0.000182	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Cisplatin—hematologic cancer	3.2e-05	0.000182	CcSEcCtD
Nitrofurantoin—Headache—Alitretinoin—hematologic cancer	3.19e-05	0.000181	CcSEcCtD
Nitrofurantoin—Diarrhoea—Gemcitabine—hematologic cancer	3.18e-05	0.000181	CcSEcCtD
Nitrofurantoin—Nausea—Thalidomide—hematologic cancer	3.18e-05	0.000181	CcSEcCtD
Nitrofurantoin—Renal failure—Doxorubicin—hematologic cancer	3.18e-05	0.000181	CcSEcCtD
Nitrofurantoin—Dyspepsia—Triamcinolone—hematologic cancer	3.17e-05	0.000181	CcSEcCtD
Nitrofurantoin—Rash—Ifosfamide—hematologic cancer	3.17e-05	0.000181	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Methotrexate—hematologic cancer	3.17e-05	0.00018	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Doxorubicin—hematologic cancer	3.17e-05	0.00018	CcSEcCtD
Nitrofurantoin—Dizziness—Irinotecan—hematologic cancer	3.16e-05	0.00018	CcSEcCtD
Nitrofurantoin—Malaise—Prednisone—hematologic cancer	3.15e-05	0.000179	CcSEcCtD
Nitrofurantoin—Abdominal pain—Etoposide—hematologic cancer	3.14e-05	0.000179	CcSEcCtD
Nitrofurantoin—Body temperature increased—Etoposide—hematologic cancer	3.14e-05	0.000179	CcSEcCtD
Nitrofurantoin—Vertigo—Prednisone—hematologic cancer	3.13e-05	0.000178	CcSEcCtD
Nitrofurantoin—Hepatitis—Epirubicin—hematologic cancer	3.13e-05	0.000178	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Epirubicin—hematologic cancer	3.12e-05	0.000178	CcSEcCtD
Nitrofurantoin—Vomiting—Vincristine—hematologic cancer	3.12e-05	0.000177	CcSEcCtD
Nitrofurantoin—Anorexia—Betamethasone—hematologic cancer	3.12e-05	0.000177	CcSEcCtD
Nitrofurantoin—Anorexia—Dexamethasone—hematologic cancer	3.12e-05	0.000177	CcSEcCtD
Nitrofurantoin—Asthenia—Cisplatin—hematologic cancer	3.11e-05	0.000177	CcSEcCtD
Nitrofurantoin—Rash—Vincristine—hematologic cancer	3.09e-05	0.000176	CcSEcCtD
Nitrofurantoin—Headache—Vincristine—hematologic cancer	3.07e-05	0.000175	CcSEcCtD
Nitrofurantoin—Nausea—Carmustine—hematologic cancer	3.05e-05	0.000174	CcSEcCtD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—hematologic cancer	3.04e-05	0.00626	CbGpPWpGaD
Nitrofurantoin—Vomiting—Irinotecan—hematologic cancer	3.04e-05	0.000173	CcSEcCtD
Nitrofurantoin—Vomiting—Mitoxantrone—hematologic cancer	3.04e-05	0.000173	CcSEcCtD
Nitrofurantoin—Nausea—Alitretinoin—hematologic cancer	3.02e-05	0.000172	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Doxorubicin—hematologic cancer	3.02e-05	0.000172	CcSEcCtD
Nitrofurantoin—Rash—Irinotecan—hematologic cancer	3.01e-05	0.000171	CcSEcCtD
Nitrofurantoin—Rash—Mitoxantrone—hematologic cancer	3.01e-05	0.000171	CcSEcCtD
Nitrofurantoin—Chills—Methotrexate—hematologic cancer	3.01e-05	0.000171	CcSEcCtD
Nitrofurantoin—Headache—Irinotecan—hematologic cancer	2.99e-05	0.00017	CcSEcCtD
Nitrofurantoin—Headache—Mitoxantrone—hematologic cancer	2.99e-05	0.00017	CcSEcCtD
Nitrofurantoin—Nausea—Ifosfamide—hematologic cancer	2.99e-05	0.00017	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	2.98e-05	0.00017	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	2.98e-05	0.00017	CcSEcCtD
Nitrofurantoin—Myalgia—Prednisone—hematologic cancer	2.97e-05	0.000169	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Triamcinolone—hematologic cancer	2.97e-05	0.000169	CcSEcCtD
Nitrofurantoin—Diarrhoea—Cisplatin—hematologic cancer	2.97e-05	0.000169	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Epirubicin—hematologic cancer	2.96e-05	0.000169	CcSEcCtD
Nitrofurantoin—Alopecia—Methotrexate—hematologic cancer	2.96e-05	0.000168	CcSEcCtD
Nitrofurantoin—Vomiting—Gemcitabine—hematologic cancer	2.96e-05	0.000168	CcSEcCtD
Nitrofurantoin—Paraesthesia—Betamethasone—hematologic cancer	2.94e-05	0.000167	CcSEcCtD
Nitrofurantoin—Paraesthesia—Dexamethasone—hematologic cancer	2.94e-05	0.000167	CcSEcCtD
Nitrofurantoin—Discomfort—Prednisone—hematologic cancer	2.93e-05	0.000167	CcSEcCtD
Nitrofurantoin—Rash—Gemcitabine—hematologic cancer	2.93e-05	0.000167	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Etoposide—hematologic cancer	2.93e-05	0.000167	CcSEcCtD
Nitrofurantoin—Headache—Gemcitabine—hematologic cancer	2.91e-05	0.000166	CcSEcCtD
Nitrofurantoin—Nausea—Vincristine—hematologic cancer	2.91e-05	0.000166	CcSEcCtD
Nitrofurantoin—Hepatitis—Doxorubicin—hematologic cancer	2.9e-05	0.000165	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Prednisolone—hematologic cancer	2.89e-05	0.000164	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Doxorubicin—hematologic cancer	2.89e-05	0.000164	CcSEcCtD
Nitrofurantoin—Dyspepsia—Dexamethasone—hematologic cancer	2.88e-05	0.000164	CcSEcCtD
Nitrofurantoin—Dyspepsia—Betamethasone—hematologic cancer	2.88e-05	0.000164	CcSEcCtD
Nitrofurantoin—Asthenia—Etoposide—hematologic cancer	2.85e-05	0.000162	CcSEcCtD
Nitrofurantoin—Body temperature increased—Triamcinolone—hematologic cancer	2.85e-05	0.000162	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Prednisone—hematologic cancer	2.85e-05	0.000162	CcSEcCtD
Nitrofurantoin—Decreased appetite—Dexamethasone—hematologic cancer	2.84e-05	0.000162	CcSEcCtD
Nitrofurantoin—Decreased appetite—Betamethasone—hematologic cancer	2.84e-05	0.000162	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—TERT—hematologic cancer	2.84e-05	0.00585	CbGpPWpGaD
Nitrofurantoin—Nausea—Irinotecan—hematologic cancer	2.84e-05	0.000161	CcSEcCtD
Nitrofurantoin—Nausea—Mitoxantrone—hematologic cancer	2.84e-05	0.000161	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.82e-05	0.000161	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.82e-05	0.000161	CcSEcCtD
Nitrofurantoin—Chills—Epirubicin—hematologic cancer	2.81e-05	0.00016	CcSEcCtD
Nitrofurantoin—Alopecia—Epirubicin—hematologic cancer	2.77e-05	0.000158	CcSEcCtD
Nitrofurantoin—Nausea—Gemcitabine—hematologic cancer	2.76e-05	0.000157	CcSEcCtD
Nitrofurantoin—Vomiting—Cisplatin—hematologic cancer	2.76e-05	0.000157	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Doxorubicin—hematologic cancer	2.74e-05	0.000156	CcSEcCtD
Nitrofurantoin—Rash—Cisplatin—hematologic cancer	2.73e-05	0.000156	CcSEcCtD
Nitrofurantoin—Diarrhoea—Etoposide—hematologic cancer	2.72e-05	0.000155	CcSEcCtD
Nitrofurantoin—Anorexia—Prednisone—hematologic cancer	2.71e-05	0.000154	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Methotrexate—hematologic cancer	2.71e-05	0.000154	CcSEcCtD
Nitrofurantoin—Anaemia—Methotrexate—hematologic cancer	2.7e-05	0.000153	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Dexamethasone—hematologic cancer	2.69e-05	0.000153	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Betamethasone—hematologic cancer	2.69e-05	0.000153	CcSEcCtD
Nitrofurantoin—Flatulence—Epirubicin—hematologic cancer	2.69e-05	0.000153	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Betamethasone—hematologic cancer	2.67e-05	0.000152	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.67e-05	0.000152	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Triamcinolone—hematologic cancer	2.66e-05	0.000151	CcSEcCtD
Nitrofurantoin—Malaise—Methotrexate—hematologic cancer	2.63e-05	0.00015	CcSEcCtD
Nitrofurantoin—Dizziness—Etoposide—hematologic cancer	2.63e-05	0.00015	CcSEcCtD
Nitrofurantoin—Vertigo—Methotrexate—hematologic cancer	2.62e-05	0.000149	CcSEcCtD
Nitrofurantoin—Leukopenia—Methotrexate—hematologic cancer	2.61e-05	0.000149	CcSEcCtD
Nitrofurantoin—Chills—Doxorubicin—hematologic cancer	2.6e-05	0.000148	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.59e-05	0.000148	CcSEcCtD
Nitrofurantoin—Dizziness—Prednisolone—hematologic cancer	2.59e-05	0.000147	CcSEcCtD
Nitrofurantoin—Asthenia—Triamcinolone—hematologic cancer	2.59e-05	0.000147	CcSEcCtD
Nitrofurantoin—Body temperature increased—Betamethasone—hematologic cancer	2.58e-05	0.000147	CcSEcCtD
Nitrofurantoin—Abdominal pain—Betamethasone—hematologic cancer	2.58e-05	0.000147	CcSEcCtD
Nitrofurantoin—Body temperature increased—Dexamethasone—hematologic cancer	2.58e-05	0.000147	CcSEcCtD
Nitrofurantoin—Abdominal pain—Dexamethasone—hematologic cancer	2.58e-05	0.000147	CcSEcCtD
Nitrofurantoin—Nausea—Cisplatin—hematologic cancer	2.58e-05	0.000147	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—EP300—hematologic cancer	2.57e-05	0.00529	CbGpPWpGaD
Nitrofurantoin—Alopecia—Doxorubicin—hematologic cancer	2.56e-05	0.000146	CcSEcCtD
Nitrofurantoin—Paraesthesia—Prednisone—hematologic cancer	2.56e-05	0.000146	CcSEcCtD
Nitrofurantoin—Cough—Methotrexate—hematologic cancer	2.54e-05	0.000145	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Epirubicin—hematologic cancer	2.53e-05	0.000144	CcSEcCtD
Nitrofurantoin—Vomiting—Etoposide—hematologic cancer	2.53e-05	0.000144	CcSEcCtD
Nitrofurantoin—Anaemia—Epirubicin—hematologic cancer	2.52e-05	0.000144	CcSEcCtD
Nitrofurantoin—Dyspepsia—Prednisone—hematologic cancer	2.51e-05	0.000143	CcSEcCtD
Nitrofurantoin—Rash—Etoposide—hematologic cancer	2.51e-05	0.000143	CcSEcCtD
Nitrofurantoin—Headache—Etoposide—hematologic cancer	2.49e-05	0.000142	CcSEcCtD
Nitrofurantoin—Flatulence—Doxorubicin—hematologic cancer	2.49e-05	0.000142	CcSEcCtD
Nitrofurantoin—Chest pain—Methotrexate—hematologic cancer	2.48e-05	0.000141	CcSEcCtD
Nitrofurantoin—Myalgia—Methotrexate—hematologic cancer	2.48e-05	0.000141	CcSEcCtD
Nitrofurantoin—Decreased appetite—Prednisone—hematologic cancer	2.48e-05	0.000141	CcSEcCtD
Nitrofurantoin—Rash—Prednisolone—hematologic cancer	2.47e-05	0.000141	CcSEcCtD
Nitrofurantoin—Malaise—Epirubicin—hematologic cancer	2.46e-05	0.00014	CcSEcCtD
Nitrofurantoin—Headache—Prednisolone—hematologic cancer	2.45e-05	0.00014	CcSEcCtD
Nitrofurantoin—Discomfort—Methotrexate—hematologic cancer	2.45e-05	0.00014	CcSEcCtD
Nitrofurantoin—Vertigo—Epirubicin—hematologic cancer	2.45e-05	0.00014	CcSEcCtD
Nitrofurantoin—Leukopenia—Epirubicin—hematologic cancer	2.44e-05	0.000139	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—AQP9—hematologic cancer	2.44e-05	0.00503	CbGpPWpGaD
Nitrofurantoin—Constipation—Prednisone—hematologic cancer	2.44e-05	0.000139	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—hematologic cancer	2.43e-05	0.00501	CbGpPWpGaD
Nitrofurantoin—Confusional state—Methotrexate—hematologic cancer	2.4e-05	0.000137	CcSEcCtD
Nitrofurantoin—Dizziness—Triamcinolone—hematologic cancer	2.38e-05	0.000136	CcSEcCtD
Nitrofurantoin—Cough—Epirubicin—hematologic cancer	2.38e-05	0.000136	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Methotrexate—hematologic cancer	2.38e-05	0.000135	CcSEcCtD
Nitrofurantoin—Nausea—Etoposide—hematologic cancer	2.36e-05	0.000134	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Prednisone—hematologic cancer	2.35e-05	0.000134	CcSEcCtD
Nitrofurantoin—Asthenia—Dexamethasone—hematologic cancer	2.35e-05	0.000134	CcSEcCtD
Nitrofurantoin—Asthenia—Betamethasone—hematologic cancer	2.35e-05	0.000134	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Doxorubicin—hematologic cancer	2.34e-05	0.000133	CcSEcCtD
Nitrofurantoin—Anaemia—Doxorubicin—hematologic cancer	2.33e-05	0.000133	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Methotrexate—hematologic cancer	2.33e-05	0.000133	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Prednisone—hematologic cancer	2.33e-05	0.000133	CcSEcCtD
Nitrofurantoin—Nausea—Prednisolone—hematologic cancer	2.33e-05	0.000132	CcSEcCtD
Nitrofurantoin—Chest pain—Epirubicin—hematologic cancer	2.32e-05	0.000132	CcSEcCtD
Nitrofurantoin—Myalgia—Epirubicin—hematologic cancer	2.32e-05	0.000132	CcSEcCtD
Nitrofurantoin—Discomfort—Epirubicin—hematologic cancer	2.3e-05	0.000131	CcSEcCtD
Nitrofurantoin—Vomiting—Triamcinolone—hematologic cancer	2.29e-05	0.00013	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—FOS—hematologic cancer	2.28e-05	0.0047	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—CREB1—hematologic cancer	2.28e-05	0.00469	CbGpPWpGaD
Nitrofurantoin—Malaise—Doxorubicin—hematologic cancer	2.28e-05	0.00013	CcSEcCtD
Nitrofurantoin—Rash—Triamcinolone—hematologic cancer	2.27e-05	0.000129	CcSEcCtD
Nitrofurantoin—Vertigo—Doxorubicin—hematologic cancer	2.27e-05	0.000129	CcSEcCtD
Nitrofurantoin—Anorexia—Methotrexate—hematologic cancer	2.27e-05	0.000129	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	2.27e-05	0.00467	CbGpPWpGaD
Nitrofurantoin—Leukopenia—Doxorubicin—hematologic cancer	2.26e-05	0.000129	CcSEcCtD
Nitrofurantoin—Headache—Triamcinolone—hematologic cancer	2.26e-05	0.000128	CcSEcCtD
Nitrofurantoin—Abdominal pain—Prednisone—hematologic cancer	2.25e-05	0.000128	CcSEcCtD
Nitrofurantoin—Body temperature increased—Prednisone—hematologic cancer	2.25e-05	0.000128	CcSEcCtD
Nitrofurantoin—Confusional state—Epirubicin—hematologic cancer	2.25e-05	0.000128	CcSEcCtD
Nitrofurantoin—Diarrhoea—Dexamethasone—hematologic cancer	2.24e-05	0.000127	CcSEcCtD
Nitrofurantoin—Diarrhoea—Betamethasone—hematologic cancer	2.24e-05	0.000127	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Epirubicin—hematologic cancer	2.23e-05	0.000127	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—CREBBP—hematologic cancer	2.22e-05	0.00457	CbGpPWpGaD
Nitrofurantoin—Cough—Doxorubicin—hematologic cancer	2.2e-05	0.000125	CcSEcCtD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—hematologic cancer	2.18e-05	0.0045	CbGpPWpGaD
Nitrofurantoin—Thrombocytopenia—Epirubicin—hematologic cancer	2.18e-05	0.000124	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.17e-05	0.000123	CcSEcCtD
Nitrofurantoin—Dizziness—Betamethasone—hematologic cancer	2.16e-05	0.000123	CcSEcCtD
Nitrofurantoin—Dizziness—Dexamethasone—hematologic cancer	2.16e-05	0.000123	CcSEcCtD
Nitrofurantoin—Myalgia—Doxorubicin—hematologic cancer	2.15e-05	0.000122	CcSEcCtD
Nitrofurantoin—Chest pain—Doxorubicin—hematologic cancer	2.15e-05	0.000122	CcSEcCtD
Nitrofurantoin—Nausea—Triamcinolone—hematologic cancer	2.14e-05	0.000122	CcSEcCtD
Nitrofurantoin—Paraesthesia—Methotrexate—hematologic cancer	2.14e-05	0.000122	CcSEcCtD
Nitrofurantoin—Discomfort—Doxorubicin—hematologic cancer	2.12e-05	0.000121	CcSEcCtD
Nitrofurantoin—Anorexia—Epirubicin—hematologic cancer	2.12e-05	0.000121	CcSEcCtD
Nitrofurantoin—Dyspnoea—Methotrexate—hematologic cancer	2.12e-05	0.000121	CcSEcCtD
Nitrofurantoin—Somnolence—Methotrexate—hematologic cancer	2.12e-05	0.00012	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Prednisone—hematologic cancer	2.1e-05	0.000119	CcSEcCtD
Nitrofurantoin—Dyspepsia—Methotrexate—hematologic cancer	2.09e-05	0.000119	CcSEcCtD
Nitrofurantoin—Vomiting—Dexamethasone—hematologic cancer	2.08e-05	0.000118	CcSEcCtD
Nitrofurantoin—Vomiting—Betamethasone—hematologic cancer	2.08e-05	0.000118	CcSEcCtD
Nitrofurantoin—Confusional state—Doxorubicin—hematologic cancer	2.08e-05	0.000118	CcSEcCtD
Nitrofurantoin—Decreased appetite—Methotrexate—hematologic cancer	2.07e-05	0.000118	CcSEcCtD
Nitrofurantoin—Rash—Dexamethasone—hematologic cancer	2.06e-05	0.000117	CcSEcCtD
Nitrofurantoin—Rash—Betamethasone—hematologic cancer	2.06e-05	0.000117	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Doxorubicin—hematologic cancer	2.06e-05	0.000117	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.05e-05	0.000117	CcSEcCtD
Nitrofurantoin—Headache—Dexamethasone—hematologic cancer	2.05e-05	0.000117	CcSEcCtD
Nitrofurantoin—Headache—Betamethasone—hematologic cancer	2.05e-05	0.000117	CcSEcCtD
Nitrofurantoin—Asthenia—Prednisone—hematologic cancer	2.04e-05	0.000116	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.03e-05	0.000115	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Doxorubicin—hematologic cancer	2.02e-05	0.000115	CcSEcCtD
Nitrofurantoin—Paraesthesia—Epirubicin—hematologic cancer	2e-05	0.000114	CcSEcCtD
Nitrofurantoin—Dyspnoea—Epirubicin—hematologic cancer	1.99e-05	0.000113	CcSEcCtD
Nitrofurantoin—Somnolence—Epirubicin—hematologic cancer	1.98e-05	0.000113	CcSEcCtD
Nitrofurantoin—Anorexia—Doxorubicin—hematologic cancer	1.96e-05	0.000112	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Methotrexate—hematologic cancer	1.96e-05	0.000112	CcSEcCtD
Nitrofurantoin—Dyspepsia—Epirubicin—hematologic cancer	1.96e-05	0.000112	CcSEcCtD
Nitrofurantoin—Diarrhoea—Prednisone—hematologic cancer	1.95e-05	0.000111	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Methotrexate—hematologic cancer	1.95e-05	0.000111	CcSEcCtD
Nitrofurantoin—Nausea—Betamethasone—hematologic cancer	1.94e-05	0.000111	CcSEcCtD
Nitrofurantoin—Nausea—Dexamethasone—hematologic cancer	1.94e-05	0.000111	CcSEcCtD
Nitrofurantoin—Decreased appetite—Epirubicin—hematologic cancer	1.94e-05	0.00011	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.92e-05	0.000109	CcSEcCtD
Nitrofurantoin—Constipation—Epirubicin—hematologic cancer	1.9e-05	0.000108	CcSEcCtD
Nitrofurantoin—ABCG2—Fluoropyrimidine Activity—TP53—hematologic cancer	1.88e-05	0.00388	CbGpPWpGaD
Nitrofurantoin—Dizziness—Prednisone—hematologic cancer	1.88e-05	0.000107	CcSEcCtD
Nitrofurantoin—Abdominal pain—Methotrexate—hematologic cancer	1.88e-05	0.000107	CcSEcCtD
Nitrofurantoin—Body temperature increased—Methotrexate—hematologic cancer	1.88e-05	0.000107	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.88e-05	0.000107	CcSEcCtD
Nitrofurantoin—Paraesthesia—Doxorubicin—hematologic cancer	1.85e-05	0.000105	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—S100A10—hematologic cancer	1.85e-05	0.00381	CbGpPWpGaD
Nitrofurantoin—Dyspnoea—Doxorubicin—hematologic cancer	1.84e-05	0.000105	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Epirubicin—hematologic cancer	1.84e-05	0.000104	CcSEcCtD
Nitrofurantoin—Somnolence—Doxorubicin—hematologic cancer	1.83e-05	0.000104	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.82e-05	0.000104	CcSEcCtD
Nitrofurantoin—Dyspepsia—Doxorubicin—hematologic cancer	1.81e-05	0.000103	CcSEcCtD
Nitrofurantoin—Vomiting—Prednisone—hematologic cancer	1.81e-05	0.000103	CcSEcCtD
Nitrofurantoin—Rash—Prednisone—hematologic cancer	1.8e-05	0.000102	CcSEcCtD
Nitrofurantoin—Decreased appetite—Doxorubicin—hematologic cancer	1.79e-05	0.000102	CcSEcCtD
Nitrofurantoin—Headache—Prednisone—hematologic cancer	1.78e-05	0.000102	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.78e-05	0.000101	CcSEcCtD
Nitrofurantoin—Constipation—Doxorubicin—hematologic cancer	1.76e-05	0.0001	CcSEcCtD
Nitrofurantoin—Abdominal pain—Epirubicin—hematologic cancer	1.76e-05	0.0001	CcSEcCtD
Nitrofurantoin—Body temperature increased—Epirubicin—hematologic cancer	1.76e-05	0.0001	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Methotrexate—hematologic cancer	1.75e-05	9.98e-05	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	1.72e-05	0.00354	CbGpPWpGaD
Nitrofurantoin—Asthenia—Methotrexate—hematologic cancer	1.71e-05	9.72e-05	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Doxorubicin—hematologic cancer	1.7e-05	9.67e-05	CcSEcCtD
Nitrofurantoin—Nausea—Prednisone—hematologic cancer	1.69e-05	9.63e-05	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.69e-05	9.59e-05	CcSEcCtD
Nitrofurantoin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—hematologic cancer	1.67e-05	0.00344	CbGpPWpGaD
Nitrofurantoin—Hypersensitivity—Epirubicin—hematologic cancer	1.64e-05	9.34e-05	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—JUN—hematologic cancer	1.64e-05	0.00338	CbGpPWpGaD
Nitrofurantoin—Abdominal pain—Doxorubicin—hematologic cancer	1.63e-05	9.27e-05	CcSEcCtD
Nitrofurantoin—Body temperature increased—Doxorubicin—hematologic cancer	1.63e-05	9.27e-05	CcSEcCtD
Nitrofurantoin—Diarrhoea—Methotrexate—hematologic cancer	1.63e-05	9.27e-05	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	1.62e-05	0.00333	CbGpPWpGaD
Nitrofurantoin—Asthenia—Epirubicin—hematologic cancer	1.6e-05	9.09e-05	CcSEcCtD
Nitrofurantoin—Dizziness—Methotrexate—hematologic cancer	1.57e-05	8.96e-05	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	1.53e-05	0.00316	CbGpPWpGaD
Nitrofurantoin—Diarrhoea—Epirubicin—hematologic cancer	1.52e-05	8.67e-05	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Doxorubicin—hematologic cancer	1.52e-05	8.64e-05	CcSEcCtD
Nitrofurantoin—Vomiting—Methotrexate—hematologic cancer	1.51e-05	8.61e-05	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—EP300—hematologic cancer	1.51e-05	0.00311	CbGpPWpGaD
Nitrofurantoin—Rash—Methotrexate—hematologic cancer	1.5e-05	8.54e-05	CcSEcCtD
Nitrofurantoin—Headache—Methotrexate—hematologic cancer	1.49e-05	8.49e-05	CcSEcCtD
Nitrofurantoin—Asthenia—Doxorubicin—hematologic cancer	1.48e-05	8.42e-05	CcSEcCtD
Nitrofurantoin—Dizziness—Epirubicin—hematologic cancer	1.47e-05	8.38e-05	CcSEcCtD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—hematologic cancer	1.43e-05	0.00295	CbGpPWpGaD
Nitrofurantoin—Vomiting—Epirubicin—hematologic cancer	1.42e-05	8.06e-05	CcSEcCtD
Nitrofurantoin—Nausea—Methotrexate—hematologic cancer	1.41e-05	8.05e-05	CcSEcCtD
Nitrofurantoin—Diarrhoea—Doxorubicin—hematologic cancer	1.41e-05	8.03e-05	CcSEcCtD
Nitrofurantoin—Rash—Epirubicin—hematologic cancer	1.4e-05	7.99e-05	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	1.4e-05	0.00289	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	1.4e-05	0.00289	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—SGK1—hematologic cancer	1.4e-05	0.00289	CbGpPWpGaD
Nitrofurantoin—Headache—Epirubicin—hematologic cancer	1.4e-05	7.94e-05	CcSEcCtD
Nitrofurantoin—Dizziness—Doxorubicin—hematologic cancer	1.36e-05	7.76e-05	CcSEcCtD
Nitrofurantoin—Nausea—Epirubicin—hematologic cancer	1.32e-05	7.53e-05	CcSEcCtD
Nitrofurantoin—Vomiting—Doxorubicin—hematologic cancer	1.31e-05	7.46e-05	CcSEcCtD
Nitrofurantoin—Rash—Doxorubicin—hematologic cancer	1.3e-05	7.4e-05	CcSEcCtD
Nitrofurantoin—Headache—Doxorubicin—hematologic cancer	1.29e-05	7.35e-05	CcSEcCtD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	1.26e-05	0.0026	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PHYH—hematologic cancer	1.25e-05	0.00257	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—FTCD—hematologic cancer	1.25e-05	0.00257	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GMPS—hematologic cancer	1.25e-05	0.00257	CbGpPWpGaD
Nitrofurantoin—Nausea—Doxorubicin—hematologic cancer	1.22e-05	6.97e-05	CcSEcCtD
Nitrofurantoin—ABCG2—Metabolism—SMPD3—hematologic cancer	1.14e-05	0.00235	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.11e-05	0.00228	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.01e-05	0.00209	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ASNS—hematologic cancer	9.99e-06	0.00206	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—DCK—hematologic cancer	9.99e-06	0.00206	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—B3GAT1—hematologic cancer	9.99e-06	0.00206	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—NUP98—hematologic cancer	9.56e-06	0.00197	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—HDC—hematologic cancer	9.47e-06	0.00195	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	9.28e-06	0.00191	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—NUP214—hematologic cancer	9.22e-06	0.0019	CbGpPWpGaD
Nitrofurantoin—ABCG2—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	9.14e-06	0.00188	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CDA—hematologic cancer	8.66e-06	0.00178	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PC—hematologic cancer	8.34e-06	0.00172	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GBA—hematologic cancer	8.05e-06	0.00166	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—SLC35B2—hematologic cancer	8.05e-06	0.00166	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—TFRC—hematologic cancer	8.05e-06	0.00166	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—MTAP—hematologic cancer	7.36e-06	0.00152	CbGpPWpGaD
Nitrofurantoin—POR—blood—hematologic cancer	6.79e-06	0.16	CbGeAlD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—CYCS—hematologic cancer	6.75e-06	0.00139	CbGpPWpGaD
Nitrofurantoin—POR—bone marrow—hematologic cancer	6.57e-06	0.155	CbGeAlD
Nitrofurantoin—ABCG2—Metabolism—FHL2—hematologic cancer	6.56e-06	0.00135	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—AGRN—hematologic cancer	6.44e-06	0.00133	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—IDH2—hematologic cancer	6.1e-06	0.00126	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—HMMR—hematologic cancer	6.1e-06	0.00126	CbGpPWpGaD
Nitrofurantoin—POR—lung—hematologic cancer	5.95e-06	0.14	CbGeAlD
Nitrofurantoin—ABCG2—Metabolism—ARNTL—hematologic cancer	5.74e-06	0.00118	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	5.64e-06	0.00116	CbGpPWpGaD
Nitrofurantoin—POR—testis—hematologic cancer	5.62e-06	0.132	CbGeAlD
Nitrofurantoin—ABCG2—Metabolism—CA9—hematologic cancer	5.58e-06	0.00115	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ACP5—hematologic cancer	5.58e-06	0.00115	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—NCOR2—hematologic cancer	5.51e-06	0.00113	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—IDH1—hematologic cancer	5.25e-06	0.00108	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—TXN—hematologic cancer	5.19e-06	0.00107	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ABCC3—hematologic cancer	5.19e-06	0.00107	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTO1—hematologic cancer	5.19e-06	0.00107	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—SPHK1—hematologic cancer	5.08e-06	0.00105	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—UGT1A1—hematologic cancer	4.88e-06	0.001	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—SLC22A1—hematologic cancer	4.75e-06	0.000977	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CRABP1—hematologic cancer	4.75e-06	0.000977	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ALOX5—hematologic cancer	4.62e-06	0.000952	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—NUP98—hematologic cancer	4.48e-06	0.000922	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ADCY7—hematologic cancer	4.35e-06	0.000895	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—NCOA3—hematologic cancer	4.35e-06	0.000895	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—NUP214—hematologic cancer	4.32e-06	0.000889	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—MTR—hematologic cancer	4.23e-06	0.000871	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ENO2—hematologic cancer	4.15e-06	0.000854	CbGpPWpGaD
Nitrofurantoin—POR—lymph node—hematologic cancer	4.07e-06	0.0959	CbGeAlD
Nitrofurantoin—ABCG2—Metabolism—GSTT1—hematologic cancer	4.02e-06	0.000829	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—SDC1—hematologic cancer	3.93e-06	0.00081	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.77e-06	0.000776	CbGpPWpGaD
Nitrofurantoin—ABCG2—Transmembrane transport of small molecules—ALB—hematologic cancer	3.53e-06	0.000726	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—NQO1—hematologic cancer	3.34e-06	0.000689	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CD44—hematologic cancer	3.34e-06	0.000689	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—CYCS—hematologic cancer	3.16e-06	0.000652	CbGpPWpGaD
Nitrofurantoin—ABCG2—blood—hematologic cancer	3.15e-06	0.0743	CbGeAlD
Nitrofurantoin—ABCG2—Metabolism—HSP90AA1—hematologic cancer	3.14e-06	0.000647	CbGpPWpGaD
Nitrofurantoin—ABCG2—bone marrow—hematologic cancer	3.05e-06	0.0719	CbGeAlD
Nitrofurantoin—ABCG2—Metabolism—GSTP1—hematologic cancer	2.79e-06	0.000574	CbGpPWpGaD
Nitrofurantoin—ABCG2—lung—hematologic cancer	2.77e-06	0.0651	CbGeAlD
Nitrofurantoin—ABCG2—Metabolism—ABCB1—hematologic cancer	2.64e-06	0.000544	CbGpPWpGaD
Nitrofurantoin—ABCG2—testis—hematologic cancer	2.61e-06	0.0614	CbGeAlD
Nitrofurantoin—ABCG2—Metabolism—NCOR1—hematologic cancer	2.56e-06	0.000528	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—GSTM1—hematologic cancer	2.56e-06	0.000528	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—MTHFR—hematologic cancer	2.26e-06	0.000466	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PIK3CG—hematologic cancer	1.9e-06	0.000392	CbGpPWpGaD
Nitrofurantoin—ABCG2—lymph node—hematologic cancer	1.89e-06	0.0445	CbGeAlD
Nitrofurantoin—ABCG2—Metabolism—CREBBP—hematologic cancer	1.76e-06	0.000363	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PIK3CD—hematologic cancer	1.67e-06	0.000345	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—ALB—hematologic cancer	1.65e-06	0.00034	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PIK3R1—hematologic cancer	1.58e-06	0.000325	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PIK3CB—hematologic cancer	1.46e-06	0.0003	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PTEN—hematologic cancer	1.26e-06	0.000259	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—EP300—hematologic cancer	1.2e-06	0.000247	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—PIK3CA—hematologic cancer	8.89e-07	0.000183	CbGpPWpGaD
Nitrofurantoin—ABCG2—Metabolism—AKT1—hematologic cancer	7.26e-07	0.00015	CbGpPWpGaD
